<DOC>
	<DOC>NCT02721368</DOC>
	<brief_summary>The purpose of this study is to determine whether Neuramis® Volume Lidocaine is effective in the temporary restoring the mid-face volume.</brief_summary>
	<brief_title>Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume</brief_title>
	<detailed_description>This study is a multi-center, randomized, evaluator and subject blind, comparative medical device pivotal clinical trial. Efficacy and safety are evaluated at the appointed time that subject visit clinical site after injecting medical device.</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>1. Male or female subject aged between 35 and 65. 2. Subject who wanting to correct his/her midface volume deficit. 3. Subject who agreed not to receive a cosmetic procedure or cosmetic surgery during the study period. 4. Subjects who voluntarily decided the participation of the study and signed the informed consent. 1. Subjects who had previous treatment at the midface for restoring volume. 2. Subjects who had skin lesion caused by congenital defect, trauma and lipodystrophy etc. 3. Subjects who had hypersensitivity to local anesthetic of amide type or lidocaine. 4. Pregnant, lactating subjects or the childbearing subjects who disagreed with medically acceptable contraception. 5. Subjects who have received any investigational product within 4 weeks prior to study participation and who are scheduled to take part in other clinical trial during the study period. 6. Subjects who had medical history such as anaphylaxis or severe complex allergy. 7. Subjects who had a mental disease which can be affect to this study or have severe disorder in the cardiovascular system, the digestive system, the respiratory system, the endocrine system and the central nervous system. 8. Patients who are not eligible for this study at the medical discretion of the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>